Clinical Characteristics and Outcomes of 82 Patients with Mixed-Phenotype Acute Leukemia
Conclusion: In this study, ALL like induction therapy or "hybrid" therapy was associated with a more than three-fold greater CR rate than AML therapy. SCT therapy showed a trend for an association with higher OS and EFS for MPAL .Key words: MPAL, Immunophenotype,Treatment strategyFundingKey Sci-Tech Research Projects of Guangdong Province (2014A02021102).DisclosuresFan: National Natural Science Foundation of China (No. 81600141, No. 81770190) and Natural Science Foundation of Guangdong Province (No. 2016A030310390): Research Funding.
Source: Blood - Category: Hematology Authors: Yang, Y. c., Gao, Y., Xu, Y., Zhang, Y., Zhu, D., Fan, Z., Liu, Q., Ping, B. Tags: 203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Chemotherapy | China Health | Clinical Trials | Leukemia | Rare Diseases | Science | Stem Cell Therapy | Stem Cells | Study | Translocation | Transplants